Nouvelle déclaration d'incident
No de la demande: 2010-1436
Numéro de référence du titulaire d'homologation: PROSAR 1-21876449
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez un animal domestique
Pays: UNITED STATES
État: LOUISIANA
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2596-125
Nom du produit: UltraGuard Flea/Tick Spray for Dogs 16 fl oz
Liquide
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Inconnu
Propriétaire de l'animal
Dog / Chien
Unknown breed
1
Homme
0.25
25
lbs
Cutanée
Orale
Unknown / Inconnu
Unknown / Inconnu
Système
Persisted until death
Non
Non
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
1-21876449: A reporter (dog owner) called on 03/10/2010 to report the exposure of her 2 dogs to a flea and tick spray containing the active ingredient Tetrachlorvinphos. According to the reporter, the product was applied to Dog #1 (1st Subform III) on 03/04 or 03/05/2010. The dog was seen licking the product off itself on 03/05/2010. On 03/06/2010, Dog #1 developed vomiting, diarrhea, and lethargy. The reporter treated the dog with Kao-Pectate and the signs persisted. The reporter called her veterinarian who suspected Parvovirus as the reason for the signs. Dog #1 was not seen by a veterinarian and died on 03/09/2010. Dog #2 (2nd Subform III) was treated with the product on 03/09/2010. By that evening, the dog had developed vomiting and diarrhea. The reporter was advised that the product has a wide range of safety and ingestion of small amounts from the hair coat are not expected to result in the signs described. A recommendation was made to have the dog evaluated by a veterinarian. The company's cholinesterase testing program was mentioned. On follow up on 03/11/2010, the reporter stated that Dog #2 was not evaluated by a veterinarian, and that his signs resolved within 1.5 days. The reporter called back spontaneously on 03/12/2010 to report that Dog #2 was having signs again and that she planned to take him to the veterinarian. The reporter was advised that veterinary evaluation is recommended, and the company's reimbursement policy was discussed. On follow up on 03/17/2010, the reporter stated that Dog #2 was taken back to the veterinarian and treated with IV fluids, medications for gastrointestinal upset, and antibiotics for an ear infection. No further information was obtained.
Mort
Propriétaire de l'animal
Dog / Chien
Boston Terrier
1
Homme
0.25
4.5
lbs
Cutanée
Unknown / Inconnu
>8 hrs <=24 hrs / > 8 h < = 24 h
Système
Unknown / Inconnu
Oui
Inconnu
Fully Recovered / Complètement rétabli
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
1-21876449: A reporter (dog owner) called on 03/10/2010 to report the exposure of her 2 dogs to a flea and tick spray containing the active ingredient Tetrachlorvinphos. According to the reporter, the product was applied to Dog #1 (1st Subform III) on 03/04 or 03/05/2010. The dog was seen licking the product off itself on 03/05/2010. On 03/06/2010, Dog #1 developed vomiting, diarrhea, and lethargy. The reporter treated the dog with Kao-Pectate and the signs persisted. The reporter called her veterinarian who suspected Parvovirus as the reason for the signs. Dog #1 was not seen by a veterinarian and died on 03/09/2010. Dog #2 (2nd Subform III) was treated with the product on 03/09/2010. By that evening, the dog had developed vomiting and diarrhea. The reporter was advised that the product has a wide range of safety and ingestion of small amounts from the hair coat are not expected to result in the signs described. A recommendation was made to have the dog evaluated by a veterinarian. The company's cholinesterase testing program was mentioned. On follow up on 03/11/2010, the reporter stated that Dog #2 was not evaluated by a veterinarian, and that his signs resolved within 1.5 days. The reporter called back spontaneously on 03/12/2010 to report that Dog #2 was having signs again and that she planned to take him to the veterinarian. The reporter was advised that veterinary evaluation is recommended, and the company's reimbursement policy was discussed. On follow up on 03/17/2010, the reporter stated that Dog #2 was taken back to the veterinarian and treated with IV fluids, medications for gastrointestinal upset, and antibiotics for an ear infection. No further information was obtained.
Modérée